Page 206 - Computational Modeling in Biomedical Engineering and Medical Physics

Magnetic drug targeting 195

Figure 6.20 Heat entrainment by the MAF flow shown through isotherm profiles—see the
moments A, B in Fig. 6.16. MAF, Magnetizable aggregate fluid.

the reason that an increased drug quantity is administrated at the major place of swell-
ing while reducing the undesired toxicity. This posology has though the foremost
drawback that the drug fast vanishes from the joint nook, requiring recurring injec-
tions, which may produce affliction and dysfunctions of the joints. Retard medication
is then often recommended but it is constantly linked with negative collateral effects,
mainly when the medication is provided orally or systemically.
To alleviate these difficulties while maintaining the requested amount longer
could be to instill the medication attached to MNPs and use magnetic fields to
increase the retention of the active admixture in the joint nook and to enhance their
in situ effect (Schulze et al., 2005; Butoescu et al., 2009). Some difficulties of this
MDT protocol, for example, limited penetration depth and distribution of the
released drug to the disease site, were evidenced through preclinical studies though,
but these can be surpassed by active directing through the attachment of ligands of
high affinity onto the MNP surface (Cheginietal.,2018). There are very few studies
that address this method though, and significant unmet needs in the joint treatment
persist.
The tissues concerned in the joint maladies mainly consist of the synovial mem-
brane, the capsular tissue, the hyaline cartilage, and the subchondral bone, where
synoviocytes, chondrocytes, and osteoblasts play a major role. These cells come from the
mesoderm level in embryogenesis, and, in compliance to the environment, they trans-
form in their final form. Chronic swelling can lead to dedifferentiation (e.g., fibrous
tissue), which is normally associated with a loss of function that is damaging to the
overall functionality of the joint. The hyaline cartilage degenerates into fibrocartilage